Rigobello A
Lacking FDA approval and recent extensive peer-reviewed data, its use for anti-aging, bodybuilding, or other non-FDA approved purposes is not evidence-based and carries substantial risks, including reported hypersensitivity reactions and unknown long-term endocrine disruption [fda.gov], [mayoclinic.org]
[PubMed] [Google Scholar] 56.Shibuya M
Agarwal P, Leurgans SE, Agrawal S, Aggarwal NT, Cherian LJ, James BD, et al
Market Layout - ** Key Regions **: Deeply cultivate the markets of Southeast Asia and the Middle East, and establish [XX] overseas warehouses in Europe - ** Customer Group **: Serving multinational retailers - ** Emerging Expansion **: Focusing on the markets of RCEP member countries, cross-border e-commerce business grew by 120% in 2023 V